<DOC>
	<DOCNO>NCT01279954</DOCNO>
	<brief_summary>The purpose study assess safety efficacy abatacept treatment uveitis .</brief_summary>
	<brief_title>Abatacept Treatment Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>patient visionthreatening autoimmune uveitis failure respond prednisone least one systemic immunosuppressive , intolerance medication due side effect serious concomitant illness could interfere subject 's participation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>